78 related articles for article (PubMed ID: 4735639)
1. Time course of dependence and tolerance development in rats treated with "slow release" morphine suspensions.
Frederickson RC; Smits SE
Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):867-70. PubMed ID: 4735639
[No Abstract] [Full Text] [Related]
2. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
Yano I; Takemori AE
Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
[TBL] [Abstract][Full Text] [Related]
3. Various factors which affect the rate of development of tolerance and physical dependence to abused drugs.
Dewey WL
NIDA Res Monogr; 1984; 54():39-49. PubMed ID: 6442762
[No Abstract] [Full Text] [Related]
4. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
Windh RT; Little PJ; Kuhn CM
J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantitative assessment of morphine tolerance and physical dependence.
Way EL; Loh HH; Shen FH
J Pharmacol Exp Ther; 1969 May; 167(1):1-8. PubMed ID: 5814495
[No Abstract] [Full Text] [Related]
6. Experimental studies on the effective procedure to inhibit the development of tolerance to and dependence on morphine.
Matsuda K
Arzneimittelforschung; 1970 Oct; 20(10):1596-604. PubMed ID: 4993919
[No Abstract] [Full Text] [Related]
7. Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence.
Cicero TJ; Meyer ER
J Pharmacol Exp Ther; 1973 Feb; 184(2):404-8. PubMed ID: 4734581
[No Abstract] [Full Text] [Related]
8. Morphine dependence and self-stimulation: attenuation of withdrawal-induced weight loss.
Glick SD; Marsanico RG; Zimmerberg B; Charap AD
Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):725-32. PubMed ID: 4735638
[No Abstract] [Full Text] [Related]
9. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists.
Jacob JJ; Barthelemy CD; Tremblay EC; Colombel MC
Adv Biochem Psychopharmacol; 1973; 8(0):299-318. PubMed ID: 4800176
[No Abstract] [Full Text] [Related]
10. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
11. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence.
Gu G; Kondo I; Hua XY; Yaksh TL
J Pharmacol Exp Ther; 2005 Sep; 314(3):1362-9. PubMed ID: 15908510
[TBL] [Abstract][Full Text] [Related]
12. Influence of morphine tolerance and withdrawal on intestinal salt and water transport in the rat in vivo and in vitro.
Warhurst G; Smith GS; Higgs N; Tonge A; Turnberg LA
Gastroenterology; 1984 Nov; 87(5):1035-41. PubMed ID: 6541171
[TBL] [Abstract][Full Text] [Related]
13. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
14. [A comprehensive study of the neurochemical and immune mechanisms of morphine tolerance: the effects of naloxone].
Litvinova SV; Shul'govskiĭ VV; Gruden' MA; Panchenko LF; Terebilina NN; Aristova VV; Kaliuzhnyĭ AL
Patol Fiziol Eksp Ter; 2000; (1):6-9. PubMed ID: 10741178
[TBL] [Abstract][Full Text] [Related]
15. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
16. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
Kreeger JS; Larson AA
J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of three methods of inducing physical dependence to morphine in rats using short-term medication].
Suzuki T; Futakata A; Shimada M; Yoshii T; Yanaura S
Yakubutsu Seishin Kodo; 1984 Sep; 4(2):149-56. PubMed ID: 6543077
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
19. Effect of agonist-antagonist interaction on the development of tolerance and dependence.
Cochin J; Mushlin BE
Ann N Y Acad Sci; 1976; 281():244-51. PubMed ID: 190935
[No Abstract] [Full Text] [Related]
20. Aquaporin 4 deficiency modulates morphine pharmacological actions.
Wu N; Lu XQ; Yan HT; Su RB; Wang JF; Liu Y; Hu G; Li J
Neurosci Lett; 2008 Dec; 448(2):221-5. PubMed ID: 18973795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
